Mortality in Friedreich Ataxia

被引:231
作者
Tsou, Amy Y. [1 ]
Paulsen, Erin K. [1 ,2 ,3 ]
Lagedrost, Sarah J. [1 ,2 ,3 ]
Perlman, Susan L. [4 ]
Mathews, Katherine D. [5 ]
Wilmot, George R. [6 ]
Ravina, Bernard [7 ]
Koeppen, Arnulf H. [8 ,9 ]
Lynch, David R. [1 ,2 ,3 ]
机构
[1] Univ Penn, Sch Med, Dept Neurol, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA
[3] Childrens Hosp Philadelphia, Philadelphia, PA USA
[4] Univ Calif Los Angeles, Los Angeles, CA USA
[5] Univ Iowa, Iowa City, IA USA
[6] Emory Univ, Atlanta, GA 30322 USA
[7] Univ Rochester, Rochester, NY USA
[8] VA Hosp, Albany, NY USA
[9] Albany Med Coll, Albany, NY 12208 USA
关键词
Cerebellum; Sensory; Cardiomyopathy; Echocardiogram; Arrhythmia; Neurodegenerative disease; SURVIVAL; FEATURES; DISEASE; ONSET;
D O I
10.1016/j.jns.2011.05.023
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Although cardiac dysfunction is widely accepted as the most common cause of mortality in Friedreich ataxia (FRDA), no studies have evaluated this since the advent of specific clinical and genetic diagnostic criteria. Methods: We performed a retrospective study of FRDA patients to determine cause of death followed by a case-control analysis comparing characteristics of deceased patients with living, age- and sex-matched FRDA controls. Results: Causes of death were cardiac dysfunction (59%), probable cardiac dysfunction (3.3%), non-cardiac (27.9%) or unknown (9.8%). Compared to non-cardiac deaths, cardiac deaths occurred earlier in the disease course (median 29 vs. 17 years respectively). Congestive heart failure and arrhythmia were common causes of cardiac-related death. Compared to living, matched FRDA controls, deceased patients had longer triplet repeat lengths and higher rates of arrhythmia and dilated cardiomyopathy. The presence of hypertrophic cardiomyopathy did not differ between deceased and living patients. Conclusion: Cardiac dysfunction was the most frequent cause of death (59%), most commonly from congestive heart failure or arrhythmia. Arrhythmia and dilated cardiomyopathy were significantly more common in deceased patients compared to matched FRDA controls, while in contrast, the presence of cardiac hypertrophy did not differ. More research is needed to establish the clinical significance of hypertrophy in FRDA. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:46 / 49
页数:4
相关论文
共 11 条
[1]   CARDIAC INVOLVEMENT IN FRIEDREICHS ATAXIA - A CLINICAL-STUDY OF 75 PATIENTS [J].
CHILD, JS ;
PERLOFF, JK ;
BACH, PM ;
WOLFE, AD ;
PERLMAN, S ;
KARK, RAP .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1986, 7 (06) :1370-1378
[2]   Friedreich ataxia: an overview [J].
Delatycki, MB ;
Williamson, R ;
Forrest, SM .
JOURNAL OF MEDICAL GENETICS, 2000, 37 (01) :1-8
[3]   Age of onset, sex, and cardiomyopathy as predictors of disability and survival in Friedreich's disease: A retrospective study on 119 patients [J].
DeMichele, G ;
Perrone, F ;
Filla, A ;
Mirante, E ;
Giordano, M ;
DePlacido, S ;
Campanella, G .
NEUROLOGY, 1996, 47 (05) :1260-1264
[4]   Clinical and genetic abnormalities in patients with Friedreich's ataxia [J].
Durr, A ;
Cossee, M ;
Agid, Y ;
Campuzano, V ;
Mignard, C ;
Penet, C ;
Mandel, JL ;
Brice, A ;
Koenig, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (16) :1169-1175
[5]   FRIEDREICH ATAXIA - A CLINICAL AND GENETIC-STUDY OF 90 FAMILIES WITH AN ANALYSIS OF EARLY DIAGNOSTIC-CRITERIA AND INTRAFAMILIAL CLUSTERING OF CLINICAL-FEATURES [J].
HARDING, AE .
BRAIN, 1981, 104 (SEP) :589-620
[6]   STUDY OF FATAL CASES OF FRIEDREICHS ATAXIA [J].
HEWER, RL .
BRITISH MEDICAL JOURNAL, 1968, 3 (5619) :649-&
[7]   FRIEDREICHS DISEASE - SURVIVAL ANALYSIS IN AN ITALIAN POPULATION [J].
LEONE, M ;
ROCCA, WA ;
ROSSO, MG ;
MANTEL, N ;
SCHOENBERG, BS ;
SCHIFFER, D .
NEUROLOGY, 1988, 38 (09) :1433-1438
[8]   Measuring Friedreich ataxia - Complementary features of examination and performance measures [J].
Lynch, DR ;
Farmer, JM ;
Tsou, AY ;
Perlman, S ;
Subramony, SH ;
Gomez, CM ;
Ashizawa, T ;
Wilmot, GR ;
Wilson, RB ;
Balcer, LJ .
NEUROLOGY, 2006, 66 (11) :1711-1716
[9]   Friedreich ataxia - Effects of genetic understanding on clinical evaluation and therapy [J].
Lynch, DR ;
Farmer, JM ;
Balcer, LJ ;
Wilson, RB .
ARCHIVES OF NEUROLOGY, 2002, 59 (05) :743-747
[10]   Idebenone treatment in Friedreich patients: One-year-long randomized placebo-controlled trial [J].
Mariotti, C ;
Solari, A ;
Torta, D ;
Marano, L ;
Fiorentini, C ;
Di Donato, S .
NEUROLOGY, 2003, 60 (10) :1676-1679